Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Special https://ift.tt/2Rxkbqa

Comments

Popular posts from this blog

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

Asteroid Discovery Suggests Ingredients for Life on Earth Came From Space

Smith's Horrible DRS Call Has Kohli In Splits. 'Worst Review' Says Twitter